128 related articles for article (PubMed ID: 10584560)
1. [Genetic background in carcinogenesis].
Suzuki T; Kanamaru R
Gan To Kagaku Ryoho; 1999 Nov; 26(13):1971-9. PubMed ID: 10584560
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
3. DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.
Dufloth RM; Costa S; Schmitt F; Zeferino LC
Genet Mol Res; 2005 Dec; 4(4):771-82. PubMed ID: 16475125
[TBL] [Abstract][Full Text] [Related]
4. [Genetic factors involved in cancer susceptibility].
Kohno T; Yokota J
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1255-62. PubMed ID: 12146010
[TBL] [Abstract][Full Text] [Related]
5. Hereditary aspects of gastric cancer.
Keller G
Pathologica; 2002 Oct; 94(5):229-33. PubMed ID: 12417969
[TBL] [Abstract][Full Text] [Related]
6. [Genetic predisposition to cancer].
Bressac B; Grand-Jouan S
Rev Prat; 1992 Apr; 42(7):803-10. PubMed ID: 1604200
[TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
8. Genetic predisposition to colorectal cancer.
de la Chapelle A
Nat Rev Cancer; 2004 Oct; 4(10):769-80. PubMed ID: 15510158
[TBL] [Abstract][Full Text] [Related]
9. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
12. Testing for cancer susceptibility genes in children.
Laxova R
Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
[TBL] [Abstract][Full Text] [Related]
13. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas.
Isidro G; Laranjeira F; Pires A; Leite J; Regateiro F; Castro e Sousa F; Soares J; Castro C; Giria J; Brito MJ; Medeira A; Teixeira R; Morna H; Gaspar I; Marinho C; Jorge R; Brehm A; Ramos JS; Boavida MG
Hum Mutat; 2004 Oct; 24(4):353-4. PubMed ID: 15366000
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
Kiyohara C; Takayama K; Nakanishi Y
Lung Cancer; 2006 Dec; 54(3):267-83. PubMed ID: 16982113
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical study of familial adenomatous polyposis for genetic testing and management.
Li G; Tamura K; Yamamoto Y; Sashio H; Utsunomiya J; Yamamura T; Shimoyama T; Furuyama J
J Exp Clin Cancer Res; 1999 Dec; 18(4):519-29. PubMed ID: 10746979
[TBL] [Abstract][Full Text] [Related]
16. [Genetic variations of the tumor suppressor TP53: outstanding and strategies of analysis].
Rangel-López A; Piña-Sánchez P; Salcedo M
Rev Invest Clin; 2006; 58(3):254-64. PubMed ID: 16958302
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
Yang CQ; Chan KY; Ngan HY; Khoo US; Chiu PM; Chan QK; Xue WC; Cheung AN
Carcinogenesis; 2006 Jul; 27(7):1502-6. PubMed ID: 16574671
[TBL] [Abstract][Full Text] [Related]
18. [Gene testing of hereditary cancer on comprehensive gene medical examination support system].
Shirahama S; Ito T; Hosoya M; Kosaki T; Ijuin J; Kakimoto A; Ishihara Y; Tamura K; Sugai S; Arai M; Miki Y; Muto T; Utsunomiya J
Gan To Kagaku Ryoho; 2005 Jul; 32(7):957-61. PubMed ID: 16044955
[TBL] [Abstract][Full Text] [Related]
19. [Significance of the identification of hereditary cancer for routine oncological diagnosis].
Weissflog G; Wand D; Schwarz R
Dtsch Med Wochenschr; 2006 Jan; 131(1-2):26-8. PubMed ID: 16374739
[TBL] [Abstract][Full Text] [Related]
20. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population.
Karahalil B; Kocabas NA; Ozçelik T
Anticancer Res; 2006; 26(6C):4955-8. PubMed ID: 17214369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
